1. Home
  2. HNNA vs INCR Comparison

HNNA vs INCR Comparison

Compare HNNA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.32

Market Cap

76.4M

Sector

Finance

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

N/A

Current Price

$1.28

Market Cap

78.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HNNA
INCR
Founded
1989
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
78.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HNNA
INCR
Price
$10.32
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.9K
14.4K
Earning Date
12-03-2025
10-08-2025
Dividend Yield
5.50%
N/A
EPS Growth
38.04
N/A
EPS
1.27
N/A
Revenue
$35,538,000.00
$72,158,312.00
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
$7.87
N/A
Revenue Growth
19.88
N/A
52 Week Low
$8.43
$1.22
52 Week High
$13.88
$1.79

Technical Indicators

Market Signals
Indicator
HNNA
INCR
Relative Strength Index (RSI) 46.88 48.70
Support Level $9.33 $1.27
Resistance Level $10.39 $1.38
Average True Range (ATR) 0.32 0.05
MACD 0.02 0.01
Stochastic Oscillator 61.47 69.98

Price Performance

Historical Comparison
HNNA
INCR

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: